These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 37346153)

  • 21. Fecal microbiota transplant delivered via invasive routes in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials.
    Mohan BP; Loganathan P; Khan SR; Garg G; Muthusamy A; Ponnada S; Pasam RT; Chandan S; Tuteja A
    Indian J Gastroenterol; 2023 Jun; 42(3):315-323. PubMed ID: 37247177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial.
    Johnsen PH; Hilpüsch F; Cavanagh JP; Leikanger IS; Kolstad C; Valle PC; Goll R
    Lancet Gastroenterol Hepatol; 2018 Jan; 3(1):17-24. PubMed ID: 29100842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study.
    El-Salhy M; Hatlebakk JG; Gilja OH; Bråthen Kristoffersen A; Hausken T
    Gut; 2020 May; 69(5):859-867. PubMed ID: 31852769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials.
    Zhao HJ; Zhang XJ; Zhang NN; Yan B; Xu KK; Peng LH; Pan F
    Front Nutr; 2022; 9():890357. PubMed ID: 35719141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation.
    Mazzawi T; Lied GA; Sangnes DA; El-Salhy M; Hov JR; Gilja OH; Hatlebakk JG; Hausken T
    PLoS One; 2018; 13(11):e0194904. PubMed ID: 30427836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biofeedback for treatment of irritable bowel syndrome.
    Goldenberg JZ; Brignall M; Hamilton M; Beardsley J; Batson RD; Hawrelak J; Lichtenstein B; Johnston BC
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31713856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current status of fecal microbiota transplantation for irritable bowel syndrome.
    El-Salhy M; Hausken T; Hatlebakk JG
    Neurogastroenterol Motil; 2021 Nov; 33(11):e14157. PubMed ID: 34236740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota.
    Huang HL; Chen HT; Luo QL; Xu HM; He J; Li YQ; Zhou YL; Yao F; Nie YQ; Zhou YJ
    J Dig Dis; 2019 Aug; 20(8):401-408. PubMed ID: 31070838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome.
    El-Salhy M; Casen C; Valeur J; Hausken T; Hatlebakk JG
    World J Gastroenterol; 2021 May; 27(18):2219-2237. PubMed ID: 34025075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fecal microbiota transplantation in irritable bowel syndrome: A meta-analysis of randomized controlled trials.
    Samuthpongtorn C; Kantagowit P; Pittayanon R; Patcharatrakul T; Gonlachanvit S
    Front Med (Lausanne); 2022; 9():1039284. PubMed ID: 36405622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of fecal microbiota transplantation on IBS related quality of life and fatigue in moderate to severe non-constipated irritable bowel: Secondary endpoints of a double blind, randomized, placebo-controlled trial.
    Johnsen PH; Hilpüsch F; Valle PC; Goll R
    EBioMedicine; 2020 Jan; 51():102562. PubMed ID: 31877418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study.
    Holster S; Lindqvist CM; Repsilber D; Salonen A; de Vos WM; König J; Brummer RJ
    Clin Transl Gastroenterol; 2019 Apr; 10(4):e00034. PubMed ID: 31009405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
    Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
    Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
    [No Abstract]   [Full Text] [Related]  

  • 35. Procedures in Fecal Microbiota Transplantation for Treating Irritable Bowel Syndrome: Systematic Review and Meta-Analysis.
    Rodrigues T; Rodrigues Fialho S; Araújo JR; Rocha R; Moreira-Rosário A
    J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A systematic review, pairwise meta-analysis and network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in irritable bowel syndrome.
    Rokkas T; Hold GL
    Eur J Gastroenterol Hepatol; 2023 Apr; 35(4):471-479. PubMed ID: 36719820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS).
    El-Salhy M; Hausken T; Hatlebakk JG
    Nutrients; 2019 Jun; 11(6):. PubMed ID: 31238507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms.
    El-Salhy M; Mazzawi T; Hausken T; Hatlebakk JG
    Scand J Gastroenterol; 2022 Sep; 57(9):1036-1045. PubMed ID: 35486073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Efficacy of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
    Wu Y; Li Y; Zheng Q; Li L
    Nutrients; 2024 Jul; 16(13):. PubMed ID: 38999862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D.
    Singh P; Alm EJ; Kelley JM; Cheng V; Smith M; Kassam Z; Nee J; Iturrino J; Lembo A
    Gut Microbes; 2022; 14(1):2020067. PubMed ID: 35014601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.